Headache News and Research

Latest Headache News and Research

Oropouche virus could cause serious public health problem in Brazil, researcher warns

After the Zika epidemic, which began in 2015, and the outbreak of yellow fever early in 2017, Brazil runs a serious risk of being afflicted by Oropouche, another virus that is widely distributed throughout South and Central America and the Caribbean.

22 Aug 2017

NIH scientists develop laboratory model to study tickborne flaviviruses

National Institutes of Health scientists have filled a research gap by developing a laboratory model to study ticks that transmit flaviviruses, such as Powassan virus. Powassan virus was implicated in the death of a New York man earlier this year.

22 Aug 2017

New biomarkers for early Lyme Disease identified

A team of researchers led by Colorado State University has developed a test to facilitate early diagnosis of Lyme Disease, which it is hoped will improved treatment outcomes. Until now, it was difficult to distinguish Lyme disease from similar, less severe tick-borne conditions.

18 Aug 2017

FDA approves Besponsa – Pfizer’s new drug for rare form of acute lymphoblastic leukemia

The U.S. Food and Drug Administration (FDA) today approved Besponsa (inotuzumab ozogamicin) in the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) - a rare form of ALL.

17 Aug 2017

$FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL$

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

The U.S. Food and Drug Administration today approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

17 Aug 2017

Research highlights need for expert treatment to manage subarachnoid hemorrhages

Research led by the head of the Barrow Neurological Institute and published in the July 20, 2017 issue of The New England Journal of Medicine reveals that subarachnoid hemorrhages, which are caused by ruptured brain aneurysms, account for 5-10 percent of all strokes and are best managed by experienced and dedicated experts at high-volume centers with neurosurgeons, endovascular surgeons and stroke neurologists.

17 Aug 2017

Mobile health app helps improve concussion symptoms in teenagers

Generally, after suffering a concussion, patients are encouraged to avoid reading, watching TV and using mobile devices to help their brains heal.

16 Aug 2017

FDA approves new treatment for all HCV genotypes 1-6

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis.

3 Aug 2017

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

Yesterday the U.S. Food and Drug Administration gave its approval to Mavyret (glecaprevir and pibrentasvir) for the treatment of adults with chronic hepatitis C infection. These patients are infected with the Hepatitis C virus (HCV) of genotypes 1-6 and are those that have not developed liver cirrhosis or those who have developed mild cirrhosis. The approval for Mavyret was given to AbbVie Inc.

3 Aug 2017

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved updated labeling for Epclusa (sofosbuvir 400mg/velpatasvir 100mg), the first all-oral, pan-genotypic, once-daily single tablet regimen (STR) for the treatment of adults with chronic hepatitis C virus (HCV) infection, to include use in patients co-infected with HIV.

1 Aug 2017

Researchers explore ability of Florida mosquitoes to transmit chikungunya virus

University of Florida scientists are starting to better understand the ability of two Florida mosquito species to transmit two strains of chikungunya virus that have caused outbreaks of human disease around the world.

27 Jul 2017

New study examines efficacy of extended-release guanfacine in children with chronic tic disorders

A new study assessed the safety, tolerability, and effectiveness of extended-release guanfacine in children 6-17 years of age who have chronic tic disorders including Tourette's disorder.

26 Jul 2017

Kidenga app tracks mosquito activity and disease symptoms for summer travelers

Just because Zika isn't in the news as much lately, doesn't mean the mosquito-borne infection no longer is a health threat.

26 Jul 2017

Standardizing fluid intake may improve patient outcomes following bariatric surgery procedures

Nurses on the bariatric surgery care team at a Connecticut hospital were having difficulty keeping track of patients' fluid intake after hospital admission.

24 Jul 2017

Researchers find new way to protect stem cells from inflammation during wound repair

Scientists have found a new way to protect stem cells from harsh inflammation during wound repair. In a study recently published in the journal Cytotherapy, researchers in India discovered that treating mice with a common anti-inflammatory drug called celecoxib promoted stem cell survival and healing when they injected the cells into wounds.

20 Jul 2017

Headache News and Research

Latest Headache News and Research

Oropouche virus could cause serious public health problem in Brazil, researcher warns

NIH scientists develop laboratory model to study tickborne flaviviruses

New biomarkers for early Lyme Disease identified

FDA approves Besponsa – Pfizer’s new drug for rare form of acute lymphoblastic leukemia

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

Research highlights need for expert treatment to manage subarachnoid hemorrhages

Mobile health app helps improve concussion symptoms in teenagers

FDA approves new treatment for all HCV genotypes 1-6

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

Researchers explore ability of Florida mosquitoes to transmit chikungunya virus

New study examines efficacy of extended-release guanfacine in children with chronic tic disorders

Kidenga app tracks mosquito activity and disease symptoms for summer travelers

Standardizing fluid intake may improve patient outcomes following bariatric surgery procedures

Researchers find new way to protect stem cells from inflammation during wound repair

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

Fermented red clover extract decreases number and severity of menopausal hot flushes

Simple model may help forecast future migraine attacks by measuring daily stress

New treatment receives FDA approval to reduce complications of sickle cell disease

Caloric vestibular stimulation can provide relief for migraine sufferers

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Headache News and Research

Latest Headache News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in